MODY 3 (Maturity Onset Diabetes of the Young, type 3) is a monogenic form of diabetes resulting from mutations in the HNF1A gene. It typically manifests in adolescence or early adulthood, but can sometimes be detected in children. It is characterized by a progressive insulin deficiency, but patients often respond well to oral sulfonylureas.
